Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

IIR 18-075 – HSR Study

IIR 18-075
Achieving appropriate, safe, and patient-centered lung cancer screening
Renda Soylemez Wiener, MD MPH
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, MA
Funding Period: January 2019 - June 2022


Background: Lung cancer screening (LCS) reduces lung cancer death, but can also cause harm, especially when applied to patients with co-existing serious health problems. Recognizing these trade-offs, guidelines recommend that persons with “a health problem that substantially limits life expectancy or ability to have curative lung surgery” should not be screened, and that all patients considering LCS should undergo a shared decision-making (SDM) process to review LCS benefits and harms with their clinicians. Yet these recommendations are difficult to achieve, as there is little evidence to guide clinicians on which health problems or other patient factors tip the balance of LCS from net benefit to net harm, and little is known about Veteran and clinician approaches to and needs for LCS decision-making when anticipated benefit is marginal. Objectives: We propose a sequential explanatory mixed methods study with the following 3 specific aims: 1. Identify factors that predict little LCS benefit due to limited life expectancy or increased LCS harms; 2. Identify clinical patient factors associated with real-world clinician and Veteran LCS decisions; and 3. Characterize approaches to and needs for decision-making when predicted LCS benefit is marginal. Methods: Aim 1a. To determine when competing (non-lung cancer) causes of death limit LCS benefit, we will conduct a survival analysis among LCS-eligible but unscreened Veterans, building a competing risks model and applying recursive partitioning to identify clinically meaningful risk groups. Aim 1b. We will build a model to identify combinations of patient factors that predict complications of invasive procedures for LCS-detected findings. Aim 2: We will compare how well factors associated with actual LCS decisions align with factors that predict little LCS benefit (Aim 1 models), using data from 10 VA sites that tracked rates at which LCS-eligible Veterans were deemed “too sick” for LCS, were offered LCS, and accepted LCS. We will build mixed effects logistic regression models to complete these subaims: 2a-Identify patient factors associated with clinicians deeming Veterans “not appropriate” for LCS, characterizing variation across sites in offering LCS, and whether vulnerable groups (minorities, rural, homeless) are disproportionately deemed “not appropriate” for LCS. 2b- Identify clinical and demographic factors associated with Veteran decisions to decline vs accept LCS. Aim 3: We will interview up to 30 clinicians and 30 Veterans (15 who accepted, 15 who declined LCS) for whom predicted LCS benefit is marginal based on our Aim 1 models. For clinicians, we will explore beliefs about, expected outcomes of, and site-level influences on LCS decision-making, presenting vignettes to learn how providing predicted LCS benefit (Aim 1 models) affects LCS decision-making. For patients, we will explore experiences with LCS discussions, health priorities relative to LCS, and other influences on decision-making. For all participants, we will assess informational needs and preferences to support SDM at the point of care. Anticipated Impacts on Veteran's Healthcare: To maximize the life-saving potential of LCS without creating additional harms and wasting VA resources, LCS must be applied appropriately. This proposal will lay the groundwork to inform future development, testing, and implementation of a personalized decision tool to optimize patient selection for LCS and facilitate SDM between Veterans and VA clinicians at the point of care. This work is essential to achieve safe, appropriate, and Veteran-centered care as lung cancer screening is implemented across VA – a priority for our partners in the National Center for Health Promotion & Disease Prevention, the Office of Primary Care, and the National Program Office for Pulmonary Medicine. This work addresses Secretary Shulkin’s priority to focus resources efficiently on high-impact problems for Veterans.

External Links for this Project

NIH Reporter

Grant Number: I01HX002684-01

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

Learn more about Dimensions for VA.

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project


Journal Articles

  1. Núñez ER, Bolton RE, Boudreau JH, Sliwinski SK, Herbst AN, Kearney LE, Caverly TJ, Wiener RS. "It Can't Hurt!": Why Many Patients With Limited Life Expectancy Decide to Accept Lung Cancer Screening. Annals of Family Medicine. 2024 Jan 1; 22(2):95-102. [view]
  2. Slatore CG, Golden SE, Thomas T, Bumatay S, Shannon J, Davis M. "It's Really Like Any Other Study": Rural Radiology Facilities Performing Low-Dose Computed Tomography for Lung Cancer Screening. Annals of the American Thoracic Society. 2021 Dec 1; 18(12):2058-2066. [view]
  3. Boudreau JH, Miller DR, Qian S, Nunez ER, Caverly TJ, Wiener RS. Access to Lung Cancer Screening in the Veterans Health Administration: Does Geographic Distribution Match Need in the Population? Chest. 2021 Jul 1; 160(1):358-367. [view]
  4. Núñez ER, Caverly TJ, Zhang S, Glickman ME, Qian SX, Boudreau JH, Slatore CG, Miller DR, Wiener RS. Adherence to Follow-up Testing Recommendations in US Veterans Screened for Lung Cancer, 2015-2019. JAMA Network Open. 2021 Jul 1; 4(7):e2116233. [view]
  5. Núñez ER, Caverly TJ, Zhang S, Glickman ME, Qian SX, Boudreau JH, Miller DR, Slatore CG, Wiener RS. Factors Associated With Declining Lung Cancer Screening After Discussion With a Physician in a Cohort of US Veterans. JAMA Network Open. 2022 Aug 1; 5(8):e2227126. [view]
  6. Kearney LE, Butler C, Nunez ER, Qian S, Slatore CG, Spalluto L, Wiener RS. Highly variable reporting of incidental findings in a national cohort of US veterans screened for lung cancer. Clinical imaging. 2023 Aug 1; 100:21-23. [view]
  7. Núñez ER, Caverly TJ, Zhang S, Glickman ME, Qian SX, Boudreau JH, Miller DR, Wiener RS. Invasive Procedures and Associated Complications After Initial Lung Cancer Screening in a National Cohort of Veterans. Chest. 2022 Aug 1; 162(2):475-484. [view]
  8. Spalluto LB, Lewis JA, Stolldorf D, Yeh VM, Callaway-Lane C, Wiener RS, Slatore CG, Yankelevitz DF, Henschke CI, Vogus TJ, Massion PP, Moghanaki D, Roumie CL. Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center. Journal of the American College of Radiology : JACR. 2021 Jun 1; 18(6):809-819. [view]
  9. Iaccarino JM, Steiling K, Slatore CG, Drainoni ML, Wiener RS. Patient characteristics associated with adherence to pulmonary nodule guidelines. Respiratory medicine. 2020 Sep 1; 171:106075. [view]
  10. Ito Fukunaga M, Wiener RS, Slatore CG. The 2021 US Preventive Services Task Force Recommendation on Lung Cancer Screening: The More Things Stay the Same…. JAMA oncology. 2021 May 1; 7(5):684-686. [view]
  11. Núñez ER, Zhang S, Glickman ME, Qian SX, Boudreau JH, Lindenauer PK, Slatore CG, Miller DR, Caverly TJ, Wiener RS. What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening. American journal of respiratory and critical care medicine. 2024 Jan 15; 209(2):197-205. [view]
Journal Other

  1. Schweiger L, Tostado PR, Golden SE, Melzer AC, Datta S, Sullivan DR, Slatore CG. Lung Cancer Screening: Association of Lung Cancer Susceptibility and Risk with Decisional Conflict and Distress. [Abstract]. American journal of respiratory and critical care medicine. 2020 Nov 1; 201(C30):A4728. [view]

DRA: Health Systems, Cancer, Lung Disorders
DRE: Treatment - Comparative Effectiveness, TRL - Applied/Translational
Keywords: Clinical Diagnosis and Screening, Decision-Making, Effectiveness
MeSH Terms: None at this time.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.